Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. - Wikidata - wikimedia - TriplyDB

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

http://www.wikidata.org/entity/Q33237214

about

Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy EGFR Signaling in Liver Diseases The significance of genetics for cholangiocarcinoma development Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies Genetic profiling of intrahepatic cholangiocarcinoma Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma Targeted therapy in biliary tract cancers-current limitations and potentials in the future.EGFR expression in gallbladder carcinoma in North America.Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report.Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma.Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma Current management of gallbladder carcinoma.Molecular diagnosis of intrahepatic cholangiocarcinoma.Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR).Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.Molecular biology of gallbladder cancer: potential clinical implications Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma.Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.Molecular genetics and targeted therapeutics in biliary tract carcinoma.PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma.Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity.Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives.HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.Defining disease with laser precision: laser capture microdissection in gastroenterology.Current therapy and future directions in biliary tract malignancies.Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma Targeted agents: how can we improve the outcome in biliary tract cancer?Targeted therapy in biliary tract cancer: 2009 update.

P2860

Q26767120-72AB2705-8563-4921-B6EA-7A9AAD8DEFF0 Q26771265-E9F91772-953A-4ED8-BEB7-75903E49CC5E Q26865749-F714A029-0441-4164-95E7-BED6098D23B7 Q27002547-7B61FD5C-FAA0-47D4-BE1F-5D739129BBD6 Q27005787-64DCE8C9-BF39-4EEF-9BAA-FC40DF37AF64 Q27852856-C8A659A7-99BA-4431-9EB0-31D022CBB9A1 Q30234532-0FAFB924-9FF7-4DC0-A00C-71BAF3ADD9EA Q33372792-9063D27A-6F33-404C-8C59-1DCACFAFBF03 Q33723528-24FBEBAD-9C5B-47AB-93DA-46C10E35BB45 Q33750719-6376EAE5-F694-4D9F-A15B-6BF08AAFAC55 Q33757122-0CA18E6F-12F1-4EB3-8DE1-4430DB520FC9 Q33803406-52921E85-4F09-4CC7-90B9-C134CF1D8F2C Q33814916-7FD7D63B-0418-4D4F-BA8E-7C7078879485 Q34501733-2B947A85-96C4-4281-9326-D930D02909DD Q35150642-FEBA98AC-6B8E-4202-9598-F1F838282E44 Q35215602-F65CB281-83BE-4754-9BD5-E9E4BEE13353 Q35583920-55F2BAFE-084D-49A9-B81B-75D5E4495E8C Q35592221-2F797622-E5DF-4281-9F00-DDA59CF97B47 Q35615198-83C12711-1688-4789-A9A3-2209DFF10D18 Q35710375-869A427D-35C8-47A9-97C4-E5E962CB5FD2 Q36352240-CCB861FC-B2EC-4541-93A4-52EEDBC256F9 Q36370528-34F8916F-05CB-47BE-AD86-31563670222C Q36414323-16BE6ED2-96AA-46B2-9007-5B2EC9041C27 Q36421306-8FF0C65A-2CE9-4917-A917-F63FD89A2EEF Q36488070-E5DEB432-454C-4651-AFAE-409DCCD00341 Q36545534-9914BE11-9E16-4768-BE77-80D923D004FB Q36582547-0ACD189E-BDA7-41C0-9D29-A9BEEEC1D10A Q36614705-3F8FAE4C-0447-4006-8CDD-CB439C0133F8 Q36683019-77821949-FCD9-45DC-B634-8C5CDD8ABD4A Q36717363-51B96D95-36FB-487D-9C11-0DFBC8941D70 Q36870198-DCA50660-46CB-4740-80C6-DB163C2CA99F Q37004639-F9FA9F40-D243-41EE-B483-BFF916A30224 Q37073441-1F12D1AE-57F6-4840-AFDF-7245AA7C80ED Q37076843-A144F7A4-4C7D-405C-9BFF-E2BF3B263CFA Q37161293-C7064CF3-1808-4B6C-8960-A4939EFE8085 Q37177871-5853557D-C214-413C-9F86-E777C1937162 Q37215137-0B6745D8-D6CA-4B45-B70D-F10B69F4784A Q37351498-B1FD6FBE-4B56-48BD-AAC4-49C3D2ADAD87 Q37584590-A15A3BAA-6AAB-466E-9816-C2F6FEB92DB3 Q37650623-5D3ECFDD-92DF-43B6-8EA4-82CEE169D59E

P2860

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

http://www.wikidata.org/entity/Q33237214

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Somatic mutations of epidermal ...... uct and gallbladder carcinoma.

@ast

Somatic mutations of epidermal ...... uct and gallbladder carcinoma.

@en

type

label

Somatic mutations of epidermal ...... uct and gallbladder carcinoma.

@ast

Somatic mutations of epidermal ...... uct and gallbladder carcinoma.

@en

prefLabel

Somatic mutations of epidermal ...... uct and gallbladder carcinoma.

@ast

Somatic mutations of epidermal ...... uct and gallbladder carcinoma.

@en

P1433

Q33237214-B0B25C40-0ABC-4ABE-83B5-32702AB3CE1C

P1476

Q33237214-C899B218-0EC3-4623-BC3C-76882F2439D3

P2093

Q33237214-0EBC4525-73B9-4414-BC61-E5D0E094FD89

Q33237214-1316AB48-072D-4A09-8CAC-7F6B1A3E95B5

Q33237214-36E6300E-F365-4C4F-A864-DA7E5A36F6A2

Q33237214-6143E73D-D417-407C-BD58-28674276F6D4

Q33237214-E8E0D54C-A9E8-4727-BED6-83D24B3928E3

Q33237214-EE83619C-24F2-43D4-8769-B9D4B883B58F

Q33237214-F2C3A276-E01E-4918-847F-D39DD50B8746

Q33237214-FCA3E806-F04F-443C-BC9B-FA97A3DE4AB0

P304

Q33237214-87913026-AD5E-4D34-9E53-B8E4FD7D9DE5

P31

Q33237214-5CB679F6-EF07-46A4-AC03-850256118977

P356

Q33237214-8487D64F-3F0C-482A-9767-916CA6912067

P407

Q33237214-34CA0814-7763-4908-8FBF-88B341094595

P433

Q33237214-5C1B1028-16FB-40CA-BDDF-873E920D3B12

P478

Q33237214-EF52A2AF-9407-4794-BF7E-4E0901C2723A

P50

Q33237214-3590DD67-8EEA-4319-83DA-2374A3458391

Q33237214-FE8AA23E-BC3B-482F-889C-B14E2C93C2F7

P577

Q33237214-7DB3D2D6-F8FC-445F-8796-CCCDE738E323

P698

Q33237214-3FB3889B-5466-44AB-89B8-4CBDC6981EB1

P356

1078-0432.CCR-05-1692

P1433

Clinical Cancer Research

P1476

Somatic mutations of epidermal ...... duct and gallbladder carcinoma

@en

P2093

Francesco Leone

http://www.w3.org/2001/XMLSchema#string

Giuliana Cavalloni

http://www.w3.org/2001/XMLSchema#string

Ivana Sarotto

http://www.w3.org/2001/XMLSchema#string

Lorenzo Capussotti

http://www.w3.org/2001/XMLSchema#string

Mauro Risio

http://www.w3.org/2001/XMLSchema#string

Renato Ferraris

http://www.w3.org/2001/XMLSchema#string

Tiziana Venesio

http://www.w3.org/2001/XMLSchema#string

Wanda Piacibello

http://www.w3.org/2001/XMLSchema#string

P304

1680-1685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-1692

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ymera Pignochino

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16551849

http://www.w3.org/2001/XMLSchema#string